Bitcoin's recent 13% monthly decline has reignited a core market debate: is this a temporary liquidity squeeze or a fundamental challenge to its 'digital gold' narrative? Analysts are divided on the path ahead as traditional safe havens also wobble.
A deep dive into the shareholder structure of Douglas AG reveals that private equity firms, led by CVC Capital Partners, control a commanding 58% of the company, raising questions about strategic direction and long-term stability for the German beauty retailer.
A city-led operation has closed nine Tenderloin convenience stores allegedly operating as fronts for drug sales, illegal gambling, and fencing stolen goods, seizing weapons and cash in a bid to curb neighborhood crime.
Russian forces launched a wave of attacks on Ukraine's capital Kyiv and second city Kharkiv early Tuesday, targeting energy infrastructure and residential areas amid sub-zero temperatures, officials said.
Vaxcyte's shares have surged over 38% in three months, reigniting debate on whether the clinical-stage biotech is undervalued or if investors are overlooking significant risks in its unproven pipeline.
The Canadian government is moving to recover millions in past incentives following General Motors' second round of layoffs at its Oshawa plant in six months, casting a shadow over the automaker's employment pledges and future capital allocation plans.
The world's largest sovereign wealth fund has modeled a scenario where the AI-driven capital spending boom fails to deliver productivity gains, projecting a potential 53% plunge in global equities and a 35% hit to its own portfolio value.
Elon Musk's aerospace company SpaceX has finalized its acquisition of artificial intelligence firm xAI, announcing a controversial long-term strategy to develop space-based AI data centers powered by solar energy, citing insurmountable earthly constraints on power and cooling.
After a stellar 2025, mobile advertising tech leader AppLovin faced a perfect storm of challenges last month, including renewed short-seller allegations, sector-wide valuation pressures, and market jitters over Google's new AI game-creation tool.
For aspiring homeowners, where to park down payment savings is a critical calculation. With interest rates in flux, the choice between accessible high-yield accounts and locked-in CDs can significantly impact your timeline and final sum.
Shares of CTI Logistics Limited (ASX:CLX) have climbed 25% in the past three months, prompting a closer look at the company's fundamentals. While its Return on Equity appears modest, exceptional earnings growth and a consistent dividend history suggest underlying strength.
Asian equities staged a strong recovery on Tuesday, with South Korea's Kospi and Japan's Nikkei leading gains as investors returned to tech stocks. The rebound follows recent volatility, with markets now focused on corporate earnings and geopolitical risks.
The U.S. decision to slash tariffs on Indian goods has been met with cautious optimism by Indian industry, though analysts urge restraint until the full scope of the agreement is clarified.
The explosive growth of artificial intelligence and data centers is driving U.S. electricity demand to unprecedented levels, pushing consumer bills up 42% in a decade. As utilities scramble to upgrade an overburdened grid, AI itself is emerging as a critical tool to unlock next-generation power sources like fusion and geothermal energy.
Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.
The cost to insure against swings in South Korean equities has surged to unprecedented levels relative to US markets, signaling deep investor anxiety after a historic rally fueled by AI optimism shows signs of fatigue.
In a significant diplomatic and economic breakthrough, the U.S. agrees to slash tariffs on Indian goods after Prime Minister Modi commits to halt purchases of Russian crude, easing bilateral tensions and reshaping trade dynamics.
All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
